Ibio: And In The Press Release Furnished As Exhibit 99.1 To This Current Report On Form 8k Shall Not Be Deemed To Be “filed” For Purposes Of Section 18 Of The Securities Exchange Act Of 1934, As Amended, Or Otherwise Subject To The Liabilities Of That Section Or Sections 11 And 12(a)(2) Of The Securities Act Of 1933, As Amended And Shall Not Be Incorporated By Reference Into Any Filing With The U.s. Securities And Exchange Commission Made By The Company, Whether Made Before Or After The Date Hereof, Regardless Of Any General Incorporation Language In Such Filing. The Press Release Furnished As Exhibit 99.1 To This Current Report On Form 8k Includes “safe Harbor” Language Pursuant To The Private Securities Litigation Reform Act Of 1995, As Amended, Indicating That Certain Statements Contained Therein Are “forwardlooking” Rather Than Historical, Other Events, Financial Statements And Exhibits

Show full article

This functionality is available for registred users only

• Full name
  Ibio Inc
• Registration country
  USA
• Industry
  Pharmaceutical Preparation and Biotechnology
• М/S&P/F
  *** / *** / ***